These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3905266)

  • 21. HIF-1α stabilization reduces retinal degeneration in a mouse model of retinitis pigmentosa.
    Olivares-González L; Martínez-Fernández de la Cámara C; Hervás D; Millán JM; Rodrigo R
    FASEB J; 2018 May; 32(5):2438-2451. PubMed ID: 29295858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.
    Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology of retinitis pigmentosa.
    Gartner S; Henkind P
    Ophthalmology; 1982 Dec; 89(12):1425-32. PubMed ID: 7162785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina.
    Löffler KU; Edward DP; Tso MO
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):24-31. PubMed ID: 7822152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Macular diseases--application of automated static perimetry and optical coherence tomography].
    Iijima H
    Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):943-59. PubMed ID: 11193945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of secreted frizzled-related protein-2 in retinitis pigmentosa retinas.
    Jones SE; Jomary C; Grist J; Stewart HJ; Neal MJ
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1297-301. PubMed ID: 10798643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of proteins in retinas and IPM from eyes with retinitis pigmentosa.
    Schmidt SY; Heth CA; Edwards RB; Brandt JT; Adler AJ; Spiegel A; Shichi H; Berson EL
    Invest Ophthalmol Vis Sci; 1988 Nov; 29(11):1585-93. PubMed ID: 2972663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microglial-induced Müller cell gliosis is attenuated by progesterone in a mouse model of retinitis pigmentosa.
    Roche SL; Ruiz-Lopez AM; Moloney JN; Byrne AM; Cotter TG
    Glia; 2018 Feb; 66(2):295-310. PubMed ID: 29034506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa.
    Humayun MS; Prince M; de Juan E; Barron Y; Moskowitz M; Klock IB; Milam AH
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):143-8. PubMed ID: 9888437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes.
    Phelan JK; Bok D
    Mol Vis; 2000 Jul; 6():116-24. PubMed ID: 10889272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization.
    Vinores SA; Küchle M; Derevjanik NL; Henderer JD; Mahlow J; Green WR; Campochiaro PA
    Histol Histopathol; 1995 Oct; 10(4):913-23. PubMed ID: 8574012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clusterin gene expression in normal and dystrophic human retinas.
    Jomary C; Neal MJ; Jones SE
    Brain Res Mol Brain Res; 1993 Nov; 20(3):279-84. PubMed ID: 8302167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered synthesis of Bruch's membrane proteoglycans associated with dominant retinitis pigmentosa.
    Hewitt AT; Newsome DA
    Curr Eye Res; 1985 Mar; 4(3):169-74. PubMed ID: 3926382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postreceptoral contribution to macular dysfunction in retinitis pigmentosa.
    Falsini B; Iarossi G; Porciatti V; Merendino E; Fadda A; Cermola S; Buzzonetti L
    Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4282-90. PubMed ID: 8002248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients.
    Liu Y; Chen SJ; Li SY; Qu LH; Meng XH; Wang Y; Xu HW; Liang ZQ; Yin ZQ
    Stem Cell Res Ther; 2017 Sep; 8(1):209. PubMed ID: 28962643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical copper metabolism parameters in patients with retinitis pigmentosa and other tapeto-retinal degenerations.
    Ehlers N; Bülow N
    Br J Ophthalmol; 1977 Sep; 61(9):595-6. PubMed ID: 921923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of basic fibroblast growth factor in human retinas with retinitis pigmentosa.
    Li ZY; Chang JH; Milam AH
    Exp Eye Res; 1997 Dec; 65(6):855-9. PubMed ID: 9441710
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa.
    Yoshida N; Ikeda Y; Notomi S; Ishikawa K; Murakami Y; Hisatomi T; Enaida H; Ishibashi T
    Ophthalmology; 2013 Jan; 120(1):100-5. PubMed ID: 22986109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic studies on retinal tissue from a donor with a dominantly inherited chorioretinal degeneration resembling sectoral retinitis pigmentosa.
    Hollyfield JG; Frederick JM; Tabor GA; Ulshafer RJ
    Ophthalmology; 1984 Feb; 91(2):191-6. PubMed ID: 6709333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.